Study Of Nivolumab Alone, Or In Combination With Vinblastin In Patients With Classical Hodgkin Lymphoma

NCT03580408 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

64

Enrollment

OTHER

Sponsor class

Conditions

Hodgkin Lymphoma
Coexisting Medical Conditions

Interventions

DRUG: Nivolumab
DRUG: Vinblastin

Sponsor

The Lymphoma Academic Research Organisation